Member Info for Guly

The trolls have been pre-selling in the hope of a placing 😃

Very small chance of one. If there is, it will be to let in an institutional investor at a premium

Sounds like the trolls are in a spot of bother 😃

Let's not talk about the ongoing free cash the company generates on top of the healthy cash balance. Let's also not talk about the £3m coming in from the sale of the non core Australian assets by end of this year.

Let's also not mention peers are valued 5-10 times higher with much lower grades

High grade tin results must be coming early next week

Further high grade drill results imminent on tin and tungsten

As I said I can see the US taking us out within 6 months at over 10p per share

If there is a placing which is very unlikely due to the imminent sale of the Ozzy non core assets for £3m it will be at a premium for a very small amount to keep things ticking over. Don't forget the US operations generate ongoing free cash flow on top of the existing cash.

I can see a takeover over 10p within 6 months

Looking very good 👍 👌

Looking good 👍

Wake me up 5p+

Invested recently- I can see 10p on the imminent catalysts - way too cheap at 3m mcap. In the safe tier1 pro mining jurisdiction of US too. Gla

I thought you said TAO had no correlation to the share price lol. You couldn't make it up

Looks like mining right leak - could 5x tomorrow

Looks like mining right leak 🔥

Another 5 bags left if that's the case

Has to be up there with the best opportunities to make serious return 🔥

Meant huge news

Derampers out early today 😃

Huge mews - can see a move into the pennies in anticipation of a NHS contract

Looking incredibly bullish before close yesterday - can see a move into the teens in the coming sessions ahead of the mining right which the company indicates was very imminent - any day now. Don't rule out an Intra day RNS

The report makes the case that new screening technologies, such as the EpiSwitch PSE blood test from Oxford BioDynamics, should be considered in the NHS as they promise greater accuracy, fewer unnecessary procedures, and can form the foundation for a population-wide programme. EpiSwitch PSE is named in the report, highlighting its strong potential to reduce false positives and minimise the need for further diagnostic procedures in low-risk cases.

"The publication includes modelling for a future screening programme, which shows that adopting a reflex test with a balanced high specificity and sensitivity could reduce anticipated demand on MRI by more than 86% and biopsy procedures by 84%, while also saving costs for the NHS.

The findings recognise that our EpiSwitch PSE blood test, with its unmatched 97% specificity, could significantly reduce unnecessary MRIs and biopsies, and therefore help to make large-scale screening a practical reality for the NHS. This is consistent with the real-world data recently published showing PSE can enable clinics to safely avoid biopsies in up to 79% of patients with an elevated PSA2."

Wow huge news - congrats to those that held strong 🔥

Who's to say the next raise won't be at a premium with a major pharma - plenty of liquidity in the current market so cash not really a problem.